Recombinant Rat CD90/Thy1 protein (His Tag)
Species
Rat
Purity
>90 %, SDS-PAGE
Tag
His Tag
Activity
not tested
Cat no : Eg1463
Validation Data Gallery
Product Information
| Purity | >90 %, SDS-PAGE |
| Endotoxin | <1.0 EU/μg protein, LAL method |
| Activity |
Not tested |
| Expression | HEK293-derived Rat CD90/Thy1 protein Gln20-Cys130 (Accession# P01830) with a His tag at the C-terminus. |
| GeneID | 24832 |
| Accession | P01830 |
| PredictedSize | 13.8 kDa |
| SDS-PAGE | |
| Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
| Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
| Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
CD90, also known as Thy1, is a 25-35 kDa protein that is expressed on 1-4% of human fetal liver cells, cord blood cells, and bone marrow cells. CD90 is one of the essential surface molecules expressed on human MSC from bone marrow and other sources. Activation of Thy-1 has been reported to promote T cell activation. It also affects numerous nonimmunologic biological processes, including cellular adhesion, neurite outgrowth, tumor growth, migration, and cell death.
References:
1. Shaikh, Muhammad Vaseem et al. Cancer biomarkers : section A of Disease markers vol. 16,3 (2016): 301-7. 2. Schroeder, Jan-Hendrik et al. Frontiers in immunology vol. 14 (2023) 1113735. 3. Kumar, Atul et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine vol. 37,9 (2016): 11611-11622.